Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 28

Trial Status

Completed9
Terminated1

Role Distribution

Principal Investigator10
PI Rate100%

Activity Timeline

Clinical Trials (10)

NCT00000202Phase 2Completed
Buprenorphine Maintenance for Opioid Addicts - 1
Opioid-Related Disorders
Principalinvestigator
NCT00000203Phase 2Completed
Buprenorphine Maintenance for Opioid Addicts - 2
Opioid-Related Disorders
Principalinvestigator
NCT00000204Phase 2Completed
Buprenorphine Maintenance for Opioid Addicts - 3
Opioid-Related Disorders
Principalinvestigator
NCT00000276Phase 1Terminated
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
Cocaine-Related Disorders
Principalinvestigator
NCT00000277Phase 2Completed
Mazindol for Cocaine Abuse - 2
Cocaine-Related Disorders
Principalinvestigator
NCT00000278Phase 2Completed
Disulfiram for Cocaine-Alcohol Abuse - 3
Alcohol-Related DisordersCocaine-Related Disorders
Principalinvestigator
NCT00000279Phase 2Completed
Novel Medications for Opiate Detoxification - 4
Opioid-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00000280Phase 1Completed
Glutaminergic Agents for Cocaine Abuse - 5
Cocaine-Related Disorders
Principalinvestigator
NCT00000281Phase 2Completed
Pharmacotherapy for Schizophrenic Drug Users - 6
Cocaine-Related DisordersShcizophreniaSubstance-Related Disorders
Principalinvestigator
NCT00000282Phase 2Completed
Pemoline for Cocaine Abuse - 7
Cocaine-Related Disorders
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Walter Ling, M.D.

Friends Research Institute, Inc.

Related
28 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score18%

James Zacny, Ph.D.

University of Chicago

Related
17 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related DisordersAlcohol-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score18%

Herbert Kleber, M.D.

New York State Psychiatric Institute

Related
9 trials

Shared therapeutic areas:

Cocaine-Related DisordersSubstance-Related DisordersOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score18%

Mark Greenwald, PhD

Wayne State University

Related
15 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score12%

Warren Bickel, Ph.D.

University of Vermont

Related
22 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score12%

Eric C. Strain, MD

Johns Hopkins University

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score12%

Kenneth Silverman, Ph.D.

Johns Hopkins University

Related
8 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score12%

Kenzie Preston, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score12%

Selami Varol Ülker, Phd

Üsküdar University

Related
7 trials

Shared therapeutic areas:

Alcohol-Related DisordersSubstance-Related Disorders
Similarity Score12%

Metin Çınaroğlu, Phd

Istanbul Nisantasi University

Related
9 trials

Shared therapeutic areas:

Alcohol-Related DisordersSubstance-Related Disorders
Similarity Score12%

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT00000202Phase 2PrincipalInvestigator

Buprenorphine Maintenance for Opioid Addicts - 1

Opioid-Related Disorders
Completed
NCT00000203Phase 2PrincipalInvestigator

Buprenorphine Maintenance for Opioid Addicts - 2

Opioid-Related Disorders
Completed
NCT00000204Phase 2PrincipalInvestigator

Buprenorphine Maintenance for Opioid Addicts - 3

Opioid-Related Disorders
Completed
NCT00000276Phase 1PrincipalInvestigator

Dopamine Reuptake Inhibitors of Cocaine Abuse - 1

Cocaine-Related Disorders
Terminated
NCT00000277Phase 2PrincipalInvestigator

Mazindol for Cocaine Abuse - 2

Cocaine-Related Disorders
Completed
NCT00000278Phase 2PrincipalInvestigator

Disulfiram for Cocaine-Alcohol Abuse - 3

Alcohol-Related DisordersCocaine-Related Disorders
Completed
NCT00000279Phase 2PrincipalInvestigator

Novel Medications for Opiate Detoxification - 4

Opioid-Related DisordersSubstance-Related Disorders
Completed
NCT00000280Phase 1PrincipalInvestigator

Glutaminergic Agents for Cocaine Abuse - 5

Cocaine-Related Disorders
Completed
NCT00000281Phase 2PrincipalInvestigator

Pharmacotherapy for Schizophrenic Drug Users - 6

Cocaine-Related DisordersShcizophreniaSubstance-Related Disorders
Completed
NCT00000282Phase 2PrincipalInvestigator

Pemoline for Cocaine Abuse - 7

Cocaine-Related Disorders
Completed

All 10 trials loaded